|
2004 Journal Article Herpesvirus-specific CD8 T cell immunity in old age: Cytomegalovirus impairs the response to a coresident EBV infectionKhan, N, Hislop, A, Gudgeon, N, Cobbold, M, Khanna, R, Nayak, L, Rickinson, AB and Moss, PAH (2004). Herpesvirus-specific CD8 T cell immunity in old age: Cytomegalovirus impairs the response to a coresident EBV infection. Journal of Immunology, 173 (12), 7481-7489. |
|
2003 Journal Article Ex vivo analysis of T-cell responses to Epstein-Barr virus-encoded oncogene latent membrane protein 1 reveals highly conserved epitope sequences in virus isolates from diverse geographic regionsDuraiswamy, Jaikumar, Burrows, Jacqueline M., Bharadwaj, Mandvi, Burrows, Scott R., Cooper, Leanne, Pimtanothai, Nattiya and Khanna, Rajiv (2003). Ex vivo analysis of T-cell responses to Epstein-Barr virus-encoded oncogene latent membrane protein 1 reveals highly conserved epitope sequences in virus isolates from diverse geographic regions. Journal of Virology, 77 (13), 7401-7410. doi: 10.1128/JVI.77.13.7401-7410.2003 |
|
2003 Journal Article Ex vivo profiling of CD8(+)-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriersElkington, Rebecca, Walker, Susan, Crough, Tania, Menzies, Moira, Tellam, Judy, Bharadwaj, Mandvi and Khanna, Rajiv (2003). Ex vivo profiling of CD8(+)-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers. Journal of Virology, 77 (9), 5226-5240. doi: 10.1128/JVI.77.9.5226-5240.2003 |
|
2003 Journal Article Reconstitution of the latent T-lymphocyte response to Epstein-Barr virus is coincident with long-term recovery from post-transplant lymphoma after adoptive immunotherapySherritt, M. A., Bharadwaj, M., Burrows, J. M., Morrison, L. E., Elliott, S. L., Davis, J. E., Kear, L. M., Slaughter, R. E., Bell, S. C., Galbraith, A. J., Khanna, R. and Moss, D. J. (2003). Reconstitution of the latent T-lymphocyte response to Epstein-Barr virus is coincident with long-term recovery from post-transplant lymphoma after adoptive immunotherapy. Transplantation, 75 (9), 1556-1560. doi: 10.1097/01.TP.0000058745.02123.6F |
|
2003 Journal Article Proteasomal targeting of a viral oncogene abrogates oncogenic phenotype and enhances immunogenicityTellam, J, Connolly, G, Webb, N, Duraiswamy, J and Khanna, R (2003). Proteasomal targeting of a viral oncogene abrogates oncogenic phenotype and enhances immunogenicity. Blood, 102 (13), 4535-4540. doi: 10.1182/blood-2003-03-0870 |
|
2003 Journal Article Therapeutic LMP1 polyepitope vaccine for EBV-assolciated Hodgkin disease and nasopharyngeal carcinomaDuraiswamy, Jaikumar, Sherritt, Martina, Thomson, Scott, Tellam, Judy, Cooper, Leanne, Connolly, Geoff, Bharadwaj, Mandvi and Khanna, Rajiv (2003). Therapeutic LMP1 polyepitope vaccine for EBV-assolciated Hodgkin disease and nasopharyngeal carcinoma. Blood, 101 (8), 3150-3156. doi: 10.1182/blood-2002-10-3092 |
|
2003 Journal Article Promiscuous CTL recognition of viral epitopes on multiple human leukocyte antigens: Biological validation of the proposed HLA A24 supertypeBurrows, S. R., Elkington, R. A., Miles, J. J., Green, K. J., Walker, S., Haryana, S. M., Moss, D. J., Dunckley, H., Burrows, J. M. and Khanna, R. (2003). Promiscuous CTL recognition of viral epitopes on multiple human leukocyte antigens: Biological validation of the proposed HLA A24 supertype. Journal of Immunology, 171 (3), 1407-1412. doi: 10.4049/jimmunol.171.3.1407 |
|
2002 Journal Article RelB nuclear translocation mediated by C-terminal activator reigons of Epstein Barr virus-encoded latent membrane protein 1 and its effect on antigen-presenting function in B cellsPai, Saparna, O'Sullivan, Brendan J., Cooper, Leanne, Thomas, Ranjeny and Khanna, Rajiv (2002). RelB nuclear translocation mediated by C-terminal activator reigons of Epstein Barr virus-encoded latent membrane protein 1 and its effect on antigen-presenting function in B cells. Journal of Virology, 76 (4), 1914-1921. doi: 10.1128/JVI.76.4.1914-1921.2002 |
|
2002 Journal Article Will a vaccine to nasopharyngeal carcinoma retain orphan status?Moss, D. J., Khanna, R. and Bharadwaj, M. (2002). Will a vaccine to nasopharyngeal carcinoma retain orphan status?. Developments in Biologicals, 116, 252-256. |
|
2001 Journal Article Targeting of EBNA1 for rapid intracellular degradation overrides the inhibitory effects of the Gly-Ala repeat domain and restores CD8+T cell recognitionTellam, Judy, Sherritt, Martina, Thomson, Scott, Tellam, Ross, Moss, Denis J., Burrows, Scott R., Wiertz, Emmanuel and Khanna, Rajiv (2001). Targeting of EBNA1 for rapid intracellular degradation overrides the inhibitory effects of the Gly-Ala repeat domain and restores CD8+T cell recognition. Journal of Biological Chemistry, 276 (36), 33353-33360. doi: 10.1074/jbc.M104535200 |
|
2001 Journal Article Immunotherapeutic strategies for EBV-associated malignanciesKhanna, R., Tellam, J., Duraiswamy, J. and Cooper, L. (2001). Immunotherapeutic strategies for EBV-associated malignancies. Trends in Molecular Medicine, 76 (6), 270-276. doi: 10.1016/S1471-4914(01)02002-0 |
|
2001 Journal Article Contrasting Epstein-Barr virus-specific cytotoxic T cell responses to HLA A2-restricted epitopes in humans and HLA transgenic mice: implications for vaccine designSherritt, M., Bharadwaj, M., Khanna, R. and Moss, D. J. (2001). Contrasting Epstein-Barr virus-specific cytotoxic T cell responses to HLA A2-restricted epitopes in humans and HLA transgenic mice: implications for vaccine design. Vaccine, 19 (27), 3769-3777. doi: 10.1016/S0264-410X(01)00085-8 |
|
1999 Journal Article Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative diseaseKhanna, R., Bell, S., Sherritt, M., Galbraith, A., Burrows, S. R., Rafter, L., Clarke, B., Slaughter, R., Falk, M. C., Douglass, J., Williams, T., Elliott, S. L. and Moss, D. J. (1999). Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease. Proceedings of the National Academy of Sciences of the United States of America, 96 (18), 10391-10396. doi: 10.1073/pnas.96.18.10391 |
|
1999 Journal Article Cutting Edge: Silencing virus-specific cytotoxic T cell-mediated immune recognition by differential splicing: A novel implication of RNA processing for antigen presentationKienzle, Norbert, Sculley, Tom B., Greco, Sonia and Khanna, Rajiv (1999). Cutting Edge: Silencing virus-specific cytotoxic T cell-mediated immune recognition by differential splicing: A novel implication of RNA processing for antigen presentation. Journal of Immunology, 162 (12), 6963-6966. |
|
1999 Journal Article Cytotoxic T cell recognition of allelic variants of HLA B35 bound to an Epstein-Barr virus epitope: influence of peptide conformation and TCF-peptide interaction.Khanna, Rajiv, Silins, Sharon L., Weng, Zhiping, Gatchell, David, Burrows, Scott R. and Cooper, Leanne (1999). Cytotoxic T cell recognition of allelic variants of HLA B35 bound to an Epstein-Barr virus epitope: influence of peptide conformation and TCF-peptide interaction.. European Journal of Immunology, 29 (5), 1587-1597. doi: 10.1002/(SICI)1521-4141(199905)29:05 |
|
1999 Journal Article Crossreactive recognition of viral, self, and bacterial peptide ligands by human class I-restricted cytotoxic T lymphocyte clonotypes: Implications for molecular mimicry in autoimmune diseaseMisko, Ihor S., Cross, Simone M., Khanna, Rajiv, Elliott, Suzanne L., Schmidt, Christopher, Pye, Stephanie J. and Silins, Sharon L. (1999). Crossreactive recognition of viral, self, and bacterial peptide ligands by human class I-restricted cytotoxic T lymphocyte clonotypes: Implications for molecular mimicry in autoimmune disease. Proceedings of the National Academy of Sciences of the United States of America, 96 (5), 2279-2284. doi: 10.1073/pnas.96.5.2279 |
|
1999 Journal Article EBV structural antigens, gp350 and gp85, as targets for ex vivo virus-specific CTL during acute infectious mononucleosis: Potential use of gp350/gp85 CTL epitopes for vaccine designKhanna, Rajiv, Sherritt, Martina and Burrows, Scott R. (1999). EBV structural antigens, gp350 and gp85, as targets for ex vivo virus-specific CTL during acute infectious mononucleosis: Potential use of gp350/gp85 CTL epitopes for vaccine design. Journal of Immunology, 162 (5), 3063-3069. doi: 10.4049/jimmunol.162.5.3063 |
|
1999 Journal Article Direct alloreactivity by human cytotoxic T lymphocytes can be inhibited by altered peptide ligand antagonismBurrows, Scott R., Khanna, Rajiv and Moss, Denis J. (1999). Direct alloreactivity by human cytotoxic T lymphocytes can be inhibited by altered peptide ligand antagonism. Blood, 93 (3), 1020-1024. doi: 10.1182/blood.v93.3.1020 |
|
1999 Journal Article X-linked agammaglobulinemia patients are not infected with Epstein-Barr virus: Implications for the biology of the virusFaulkner, Glenda C., Burrows, Scott R., Khanna, Rajiv, Moss, Denis J., Bird, A. Graham and Crawford, Dorothy H. (1999). X-linked agammaglobulinemia patients are not infected with Epstein-Barr virus: Implications for the biology of the virus. Journal of Virology, 73 (2), 1555-1564. |
|
1999 Journal Article Immune control of EBV-associated diseases and its implication for vaccine design.Khanna, R., Moss, D. J. and Burrows, S. R. (1999). Immune control of EBV-associated diseases and its implication for vaccine design.. Immunological Reviews, 70, 49-64. |
